Ocriplasmin and its role in the management of vitreoretinal interface disorders

Int Ophthalmol Clin. 2014 Spring;54(2):29-38. doi: 10.1097/IIO.0000000000000019.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Management*
  • Fibrinolysin / pharmacology*
  • Humans
  • Peptide Fragments / pharmacology*
  • Treatment Outcome
  • Vitreoretinopathy, Proliferative / drug therapy*

Substances

  • Peptide Fragments
  • microplasmin
  • Fibrinolysin